Epigral Limited has submitted the BRSR of F.Y. 2025-26.
EPIGRAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Epigral Limited, a chemical manufacturer (100% chemicals/derivatives/specialty chemicals), has filed its BRSR for FY 2025-26. The company operates 1 plant and 4 offices in India, serving 15 countries with 3% export share. Turnover stood at Rs. 2,527.18 crore with net worth of Rs. 2,221.47 crore. The company employs 1,140 permanent staff (1.41% women) and 1,179 contract workers (4.50% women). The board has 10 members with one woman director (10%). Zero complaints were filed by any stakeholder group during the year. Epigral holds ISO 9001, ISO 14001, ISO 45001, ISO 50001, ISO 27001, ISO 37001 (Anti-Bribery), EcoVadis Silver Medal, and Responsible Care certifications. The company operates a 38.14 MW wind-solar hybrid renewable energy project and targets carbon neutrality by 2050, 50% renewable energy by 2028, and 100% employee coverage under health and safety programmes.
The BRSR filing demonstrates Epigral's strong ESG governance with measurable progress on environmental targets — 93% waste diversion and expanded renewable capacity — as well as zero corruption or ethics violations. The EcoVadis Silver rating (top 15% globally) reinforces credibility with ESG-focused investors, though low female representation (1.4% employees, 0% KMP) may attract scrutiny from governance-focused shareholders.